Dermatology World March 2011 : Page 56
facts at your fi ngertips data on display CosmeCeutiCals: a groWing business B y any measure, the business of cosmeceuticals is a growing one. Medical Insight, Inc., measured global sales and restricted itself to physician-dispensed cosmeceuticals, arriving at a figure of $775 million for 2008. This represented an increase of more than 13 percent from the previous year, with projected growth of 17 percent per year through 2012. A study of the industry by The Freedo-nia Group that included injectable botulinum toxin and tissue fillers put U.S. demand at $5.8 billion in 2008, projected to grow to $8.2 billion by 2012. Dermatologists in the U.S. who want to offer their patients cosmeceutical products in their practices may want to heed the results of Kline & Company’s Professional Skin Care 2009 Global Series: Market Analysis and Opportunities, which breaks down what U.S. patients have been buying directly from medical care providers. The report suggests that one-third of dermatologists already dispense cosme-ceuticals in their practices. It also indicates that 40 percent of non-prescription cosmeceutical sales by medical providers were related to patients’ anti-aging concerns. The report revealed the sales breakdown by category and overall sales figures below. dw 34% 33% sales of non-prescription Cosmeceuticals by u.s. medical providers 2004 $152 million 2009 $265 million 14% 13% 2014 (projected) 7% $385 million *Data for both charts used with permission from the Kline & Company Professional Skin Care 2009 Global Series: Market Analysis and Opportunities. specialty treatments moisturizers eye treatments Cleansers/ toners other The Academy has a position statement on dispensing, available online at www.aad.org. www.aad.org 56 Dermatology WorlD //March 2011
Facts At Your Fingertips
COSMECEUTICALS: A GROWING BUSINESS<br /> <br /> By any measure, the business of cosmeceuticals is a growing one. Medical Insight, Inc., measured global sales and restricted itself to physician-dispensed cosmeceuticals, arriving at a figure of $775 million for 2008. This represented an increase of more than 13 percent from the previous year, with projected growth of 17 percent per year through 2012. A study of the industry by The Freedonia Group that included injectable botulinum toxin and tissue fillers put U.S. demand at $5.8 billion in 2008, projected to grow to $8.2 billion by 2012.<br /> <br /> Dermatologists in the U.S. who want to offer their patients cosmeceutical products in their practices may want to heed the results of Kline & Company’s Professional Skin Care 2009 Global Series: Market Analysis and Opportunities, which breaks down what U.S. patients have been buying directly from medical care providers. The report suggests that one-third of dermatologists already dispense cosmeceuticals in their practices. It also indicates that 40 percent of non-prescription cosmeceutical sales by medical providers were related to patients’ anti-aging concerns. The report revealed the sales breakdown by category and overall sales figures below. <br /> <br /> <br /> Sales of Non-prescription Cosmeceuticals by U.S. Medical Providers<br /> 2004 = $152 million<br /> 2009 = $265 million<br /> 2014 (projected) = $385 million<br /> <br /> Specialty treatments: 34%<br /> Moisturizers: 33%<br /> Eye treatments: 14%<br /> Cleansers/toners: 13%<br /> Other: 7%<br /> <br /> *Data for both charts used with permission from the Kline & Company Professional Skin Care 2009 Global Series: Market<br /> Analysis and Opportunities.<br /> The Academy has a position statement on dispensing, available online at www.aad.org
Publication List
